Australia: Anteo Diagnostics: transformational acquisition
Last Updated: 2 March 2016

John Toigo and Kate Gardner in our Corporate Team, recently acted as the Australian lawyers for Anteo Diagnostics Limited (ASX:ADO), an Australian listed biotech company, in its acquisition of 100% of DIAsource ImmunoAssays S.A., a Belgium based diagnostics company, which operates in 75 countries.

This is a transformational acquisition for Anteo, providing it with an established global distribution platform, manufacturing capabilities and a significantly broadened product range. As part of this transaction John and Kate also advised Anteo on its capital raising activities (including a rights issue) to fund the acquisition.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

Some comments from our readers…
“The articles are extremely timely and highly applicable”
“I often find critical information not available elsewhere”
“As in-house counsel, Mondaq’s service is of great value”

Press Releases from this Firm
Recent Content from this Firm
By Chris Kintis
By Nerida Whelan
By Peter Karcher
By Brad Vinning, Ruby Mackenzie-Harris
By Peter Karcher, Julian Pipolo
By Tim Ferrier, Karissa Andrejic
By Brad Vinning, Ruby Mackenzie-Harris
By Brad Vinning, Ruby Mackenzie-Harris
By Murray Procter
By Jessica Rose
Font Size: